<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pone.0248103.t001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pone.0248103.t001</object-id>
 <label>Table 1</label>
 <caption>
  <title>Changes in protein expression after metformin treatment and insulin supplementation.</title>
 </caption>
 <alternatives>
  <graphic id="pone.0248103.t001g" xlink:href="pone.0248103.t001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <tbody>
    <tr>
     <td align="left" colspan="2" rowspan="1">
      <bold>proteins (15) affected by metformin treatment (|log</bold>
      <sub>
       <bold>2</bold>
      </sub>
      <bold>FC| ≥ 0.5), but not hyperinsulinemia (|log</bold>
      <sub>
       <bold>2</bold>
      </sub>
      <bold>FC| &lt; 0.5)</bold>
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">upregulated:</td>
     <td align="left" rowspan="1" colspan="1">AKT3, BDNF, CCL8, CCL28, CXCL12, ITGA2B, MIF</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">downregulated:</td>
     <td align="left" rowspan="1" colspan="1">ARVCF, CD3E, CD9, CD22, IL17A, KLK3, MKI67, RAD51C</td>
    </tr>
    <tr>
     <td align="left" colspan="2" rowspan="1">
      <bold>proteins (15) with significantly differential expression due to metformin treatment (|log</bold>
      <sub>
       <bold>2</bold>
      </sub>
      <bold>FC| ≥ 0.5 and 
       <italic>p</italic> ≤ 0.05)
      </bold>
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">upregulated:</td>
     <td align="left" rowspan="1" colspan="1">AKT3, CTSL, GFAP, GUSB, IL5, PI3, TFRC</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">downregulated:</td>
     <td align="left" rowspan="1" colspan="1">CCND2, CD63, CD81, IL1B, IL2, IL17A, IRF4, VTCN1</td>
    </tr>
    <tr>
     <td align="left" colspan="2" rowspan="1">
      <bold>proteins (9) affected by hyperinsulinemia (|log</bold>
      <sub>
       <bold>2</bold>
      </sub>
      <bold>FC| ≥ 0.5), but not metformin treatment (|log</bold>
      <sub>
       <bold>2</bold>
      </sub>
      <bold>FC| &lt; 0.5)</bold>
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">upregulated:</td>
     <td align="left" rowspan="1" colspan="1">CTSD, PRSS3, SPP1</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">downregulated:</td>
     <td align="left" rowspan="1" colspan="1">CDH2, DKK3, FAF1, HBEGF, IGLC1, PGC</td>
    </tr>
    <tr>
     <td align="left" colspan="2" rowspan="1">
      <bold>proteins (11) with significantly differential expression due to hyperinsulinemia (|log</bold>
      <sub>
       <bold>2</bold>
      </sub>
      <bold>FC| ≥ 0.5 and 
       <italic>p</italic> ≤ 0.05)
      </bold>
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">upregulated:</td>
     <td align="left" rowspan="1" colspan="1">AMFR, CEACAM8, MPP3, PLCG2, SORL1, SPP1, VEGFA, WNT2B</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">downregulated:</td>
     <td align="left" rowspan="1" colspan="1">COL1A1, FAF1, IRS2</td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t001fn001">
   <p>Compared to untreated control cells, metformin-treated cells differentially expressed 47 proteins, of which 15 were exclusively changed by the biguanide drug (and not hyperinsulinemia). Insulin-treated cells differentially expressed 40 proteins, of which 9 were exclusively changed by the pancreatic hormone (and not metformin).</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
